We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sanofi Fights To Hang On To Eloxatin

Law360 (June 15, 2007, 12:00 AM EDT) -- In a move to defend its claim to the U.S. market, Sanofi-Aventis U.S. LLC sued Sandoz Inc. Thursday for allegedly infringing a patent for its popular colon cancer drug, which a handful of other countries have already rejected.

The New Jersey district court case says that Sandoz filed an Abbreviated New Drug Application with the Food and Drug Administration for a generic version of oxaliplatin, which Sanofi holds the patents for and markets as Eloxatin.

According to the complaint, Sandoz's ANDA called the Sanofi patents, U.S....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.